Home›Search›Blood Cancer Discovery

Blood Cancer Discovery

NLM (Medline) · United States · Est. 2020

ISSN2643-3230eISSN2643-3249

SJR Q1✓ WOS ESCI✓ Scopus / SJR

/ 100

Medium Risk

Score Breakdown

✓ WoS ESCI+10

✓ Scopus Q1+25

Total45

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

4.316

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

1.483

Total Works

609

Total Citations

6,930

2yr Mean Citedness

2.75

Free JIF alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Inferred from recent articles

Blood Cancer Discovery publishes research on hematologic malignancies, including acute myeloid leukemia (AML), multiple myeloma, and B-cell lymphomas. The journal focuses on the molecular mechanisms, genetic drivers, and therapeutic vulnerabilities of these cancers. Research includes studies on gene regulation, cellular origins, treatment resistance, and novel therapeutic strategies such as CAR T-cell and CAR-NK cell therapies.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 25% in field

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published2020

Annual Volume~ 98 articles / year

StatusActive (last: 2026)

Total Publications609

Publisher OrgAmerican Association for Cancer Research

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

NLM (Medline)

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2643-3230 / 2643-3249

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q1

Cancer ResearchQ1

HematologyQ1

OncologyQ1

Subject Classification

Web of Science Categories

HematologyOncology

Scopus Categories

HematologyBiochemistry, Genetics and Molecular Biology (miscellaneous)Cancer ResearchOncology

Research Topics (OpenAlex)

Acute Myeloid Leukemia ResearchCAR-T cell therapy researchLymphoma Diagnosis and TreatmentProtein Degradation and InhibitorsChronic Lymphocytic Leukemia ResearchCancer Genomics and DiagnosticsMultiple Myeloma Research and TreatmentsAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsMonoclonal and Polyclonal Antibodies Research